Nectar Lifescience Ltd Share Price

Q: What is the share price of Nectar Lifescience Ltd today?

Nectar Lifescience Ltd share price as on 31 Jan 2025 is ₹33.91

Pharmaceuticals - Indian - Bulk Drugs & Formln M/S

NSE: NECLIFE Small Cap ISIN: INE023H01027

As on 31 January 2025 at 14:04 IST

₹33.91

+ 1.61

(4.98%)

Sell Buy

Over 1 Month

-15.49%

Over 6 Months

3.86%

Over 1 Year

-6.24%

Over 3 Years

-0.46%

Nectar Lifescience Ltd Summary

Close ₹ 33.91

Open ₹ 32.20

High ₹ 33.91

Low ₹ 31.81

Volume 6,08,582

Net Turnover (in ₹ Cr) ₹ 5.88

52Wk High ₹ 56.50

52Wk Low ₹ 26.15

52Wk High / Low

26.15

56.50

Nectar Lifescience Ltd Fundamentals

Key Financial Data

Market Cap (in ₹Cr) ₹ 724.36

EPS (TTM) 0.48

Book Value (BV) 48.06

Div. Yield -

P/E (TTM) 67.15

Price/Book Value 0.67

Delivery % -

Face Value 1

Key Ratios

PE Ratio 136.86

PB Ratio 0.63

EV to Sales 0.77

PEG Ratio -1.12

ROA 0.29

ROE 0.47

Debt-Equity 0.65

Net Profit Margin 0.26

Operating Profit Margin 8.63

Nectar Lifescience Ltd Financials

Profit and Loss

Consolidated

Standalone

Yearly

Quarterly

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	1,698.66	1,566.85	1,680.15	1,547.09	2,370.70
Total Expenses	1,680.39	1,609.27	1,646.07	1,606.54	2,333.23
Profit Before Tax	18.27	-42.42	34.08	-84.77	37.47
Profit After Tax	5	-24.18	25.05	-73.26	31.79
Operating Profit after Depreciation	105.41	37.07	112.89	52.58	163.30

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	642.71	661.97	723.10	771.89	784.85
Total Non Current Assets	907.22	958.03	1,035.98	1,149.29	1,018.15
Total Current Assets	1,283.83	1,231.18	1,354.85	1,238.83	1,615.16
TOTAL ASSETS	2,191.06	2,189.21	2,390.83	2,388.11	2,633.31
Total Shareholder's Fund	1,069.25	1,064.59	1,087.90	1,062.03	1,136.12

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	224.69	133.65	95.01	21.38	284.96
Net Cash used in Investing Activities	-17.03	51.70	16.64	-28.62	-33.13
Net Cash used in Financing Activities	-205.44	-185.58	-119.38	11.49	-251.87

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	1,698.66	1,566.85	1,679.55	1,545.62	2,367.12
Total Expenses	1,680.39	1,607.54	1,645.20	1,604.95	2,331.38
Profit Before Tax	18.28	-40.69	34.35	-84.65	35.74
Profit After Tax	5	-22.46	25.32	-73.15	30.06
Operating Profit after Depreciation	105.42	38.78	113.16	52.70	161.57

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	642.71	661.97	723.10	771.89	784.85
Total Non Current Assets	907.23	958.04	1,035.95	1,149.25	1,018.49
Total Current Assets	1,283.83	1,231.17	1,353.75	1,237.57	1,613.68
TOTAL ASSETS	2,191.06	2,189.21	2,389.71	2,386.82	2,632.17
Total Shareholder's Fund	1,069.25	1,064.60	1,086.86	1,060.73	1,134.61

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	224.69	133.37	95.04	21.33	285.65
Net Cash used in Investing Activities	-17.03	52.03	16.64	-28.62	-33.14
Net Cash used in Financing Activities	-205.44	-185.57	-119.38	11.49	-251.87

Particulars (in ₹ Cr.)	2024-09	2024-06	2024-03	2023-12	2023-09
Total Revenue	428.10	359.30	441.37	452.17	397.96
Total Expenses	384.76	319.50	392.87	409.98	371.10
Profit Before Tax	8.67	4.91	11.11	2.46	1.64
Profit After Tax	5.60	2.97	0.59	1.57	1.02
Operating Profit after Depreciation	44.03	40.35	49.97	42.67	37.47

Particulars (in ₹ Cr.)	2024-09	2024-06	2024-03	2023-12	2023-09
Total Revenue	428.10	359.30	441.37	452.17	397.96
Total Expenses	384.76	319.50	392.86	409.98	371.10
Profit Before Tax	8.67	4.91	11.12	2.46	1.64
Profit After Tax	5.60	2.97	0.60	1.57	1.02
Operating Profit after Depreciation	44.03	40.35	49.98	42.67	37.47

Nectar Lifescience Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 31.67

S2 31.03

S3 29.77

Pivot 32.93

R1 33.57

R2 34.83

R3 35.47

Moving Average

20 SMA 38.22

50 SMA 37.50

100 SMA 38.82

200 SMA 36

Nectar Lifescience Ltd Corporate Actions

Dividend

Bonus

Splits

Rights

AGM

EGM

No available data

AGM Date: 21 Sep 2022

Register of Members and Share Transfer Books shall remain closed from September 15, 2022 to September 21, 2022 (Both days inclusive) for the purpose of AGM to be held on September 21, 2022. Accordingly, the cut-off date, to ascertain the eligibility of members for remote e-voting and polling/ e-voting at AGM, is September 14, 2022 i.e. the date prior to the commencement of book closure. To convene the 27th Annual General Meeting ('AGM') of the Members of the company on Wednesday, September 21, 2022. Board Meeting, inter-alia, has decided that: 1. 27th Annual General Meeting ('AGM') of the Members of the company to be held on Wednesday, September 21, 2022 and matters related thereto. Pursuant to Regulations 30 and 34 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith copy of Annual Report for the financial year ended on March 31, 2022, containing therein inter alia, Notice of 27th Annual General Meeting to be held on September 21, 2022 at 11:00 AM. (As Per BSE Announcement Dated on 24.08.2022) Pursuant to regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, please find enclosed herewith proceedings of 27th AGM held on September 21, 2022. (As Per BSE Announcement Dated on 21.09.2022) Nectar Lifesciences Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. (As Per BSE Announcement Dated on 22.09.2022)

AGM Date: 21 Sep 2023

AGM 21/09/2023 Outcome of Board Meeting - AGM and Book Closure (As Per BSE Announcement dated on 26.05.2023) Pursuant to Regulations 30 and 34 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith copy of Annual Report for the financial year ended on March 31, 2023, containing therein inter alia: 1. Notice of 28th Annual General Meeting ('AGM'). 2. Standalone Financial Statements, Directors and Auditors Report thereon. 3. Consolidated Financial Statements and Auditors Report thereon. 4. Corporate Governance Report. 5. Management Discussion and Analysis Report along with Attendance Slip and E-voting Instructions. The above details are also available on the website of the Company. (As Per BSE Announcement Dated on 11.08.2023) Please find attached herewith the outcome of Annual General meeting held on September 21, 2023 along with scrutinizer''s report Please find attached herewith the proceedings of AGM held on September 21, 2023. (As Per BSE Announcement dated on 21.09.2023)

AGM Date: 21 Sep 2024

AGM 21/09/2024 Please find herewith the proceedings of AGM held on September 21, 2024 (As per BSE Announcement Dated on 21/09/2024) Please find enclosed herewith copy of minutes of 29th AGM of the Company. (As Per BSE Announcement Dated on 28.09.2024)

Nectar Lifescience Ltd Peer Comparison

Company	Price	Market Cap (in ₹ Cr)
Nectar Lifescience Ltd	₹32.23	₹722.79
Sun Pharmaceuticals Industries Ltd	₹1,745.25	₹4,18,743.94
Divis Laboratories Ltd	₹5,733.60	₹1,52,209.07
Cipla Ltd	₹1,458.15	₹1,17,762.24
Torrent Pharmaceuticals Ltd	₹3,357.15	₹1,13,616.11
Mankind Pharma Ltd	₹2,488.40	₹1,02,663.15

Nectar Lifescience Ltd News

Nectar Lifescience announces board meeting date

On 31 January 2025

24 Jan 2025, 04:30 pm

Nectar Lifescience schedules board meeting

On 14 November 2024

04 Nov 2024, 04:03 pm

Nectar Lifescience to conduct AGM

On 21 September 2024

20 Aug 2024, 04:12 pm

Nectar Lifescience to convene AGM

On 21 September 2024

20 Aug 2024, 10:47 am

Nectar Lifescience to conduct board meeting

On 14 August 2024

06 Aug 2024, 04:18 pm

Nectar Lifescience Ltd Stock Analysis

Annual revenue for Nectar Lifescience Ltd increased by 8.41% to ₹1,698.66 crore in FY 2024 from ₹1,566.85 crore in FY 2023.
Annual Net Profit for Nectar Lifescience Ltd decreased by 122.27% to ₹5 crore in FY 2024 from ₹-22.46 crore in FY 2023.
Promoter Shareholding in Nectar Lifescience Ltd increased by 0.40% in the most recent quarter, from 44.35% in September 2024 to 44.53% in December 2024.
Nectar Lifescience Ltd delivered a 1-year return of -6.24% compared to the Nifty 50, which provided a return of 8.03% as of the last trading session.
Nectar Lifescience Ltd share price moved up by 4.98% from its previous close of INR ₹32.30. The latest Nectar Lifescience Ltd share price is INR ₹33.91.
Nectar Lifescience Ltd share price today has been at a low of 31.81 and a high of 33.91. Over the past 52 weeks, the Nectar Lifescience Ltd share price has seen a low of 26.15 and a high of 56.50.